-
a range of issues related to labeling.
-
I put this up because in my ten years at The World Health Organization,
-
I would have loved to have seen companies
-
make this kind of commitment in the pharmaceutical industry,
-
at a time when we were facing massive problems
-
on access to pharmaceutical drugs in the area of Aids
-
or neglected tropical diseases.
-
We never got it because the industry itself could never agree
-
and second they wouldn't want to put something in writing.
-
You need to read this as being quite an important landmark decision
-
and one which you sitting outside industry should be monitoring and
-
calling to account, asking the question